title: Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
authors.affiliation: Departments of Neurology, Albert Ludwigs University Freiburg, Germany.
authors.forename: Claus Michael
authors.initials: CM
authors.lastname: Gross
authors.forename: Annette
authors.initials: A
authors.lastname: Baumgartner
authors.forename: Sebastian
authors.initials: S
authors.lastname: Rauer
authors.forename: Oliver
authors.initials: O
authors.lastname: Stich
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents; D001921:Brain / Q000187:drug effects / Q000473:pathology / Q000821:virology; D000068876:Fingolimod Hydrochloride; D006562:Herpes Zoster / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000209:etiology / Q000821:virology; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; D008775:Methylprednisolone